MIDDLE EAST & NORTH AFRICA
The region supplies products with international brand equity, as well as regionally recognised medicines which are supplied across multiple territories within Middle East and North Africa (“MENA”).
Key Countries
Algeria
Egypt
Morocco
Saudi Arabia
Turkey
United Arab Emirates

- MENA growth will be mainly driven by Egypt and Turkey over the next three years.
- The MENA region is expected to grow in USD by value at 4.6% p.a. four-year CAGR between 2019 and 2023. The largest markets are expected to be Turkey, Saudi Arabia, Egypt, Algeria, UAE and Morocco.
Source: IQVIA Market Prognosis
STATISTICS
Number of products launched:
8
(2019: 7)
Average staff turnover:
10%
(2019: 19%)
Number of product recalls:
Nil
(2019: Nil)
Number of work-related fatalities:
Nil
(2019: Nil)
Number of permanent employees | ||
82June 2020 |
79June 2019 |
Revenue | 2020 R’million |
2019 (CER) R’million |
Change % |
||||
---|---|---|---|---|---|---|---|
Regional Brands | 841 | 777 | 8 | ||||
Sterile Focus Brands | 464 | 385 | 21 | ||||
Anaesthetics Brands | 266 | 255 | 4 | ||||
Thrombosis Brands | 198 | 130 | 52 | ||||
Total | 1 305 | 1 162 | 12 |
Note: Commercial Pharmaceuticals revenue by customer geography.